Infectious Diseases Institute
College of Health Sciences, Makerere University, Uganda Investing In The Future – Impacting Real Lives
Novel Corona Virus Disease (COVID-19)
20th March 2020 Dr Solome Okware
Novel Corona Virus Disease (COVID-19) 20 th March 2020 Dr Solome - - PowerPoint PPT Presentation
Novel Corona Virus Disease (COVID-19) 20 th March 2020 Dr Solome Okware Infectious Diseases Institute College of Health Sciences, Makerere University, Uganda Investing In The Future Impacting Real Lives Outline Background Current
Infectious Diseases Institute
College of Health Sciences, Makerere University, Uganda Investing In The Future – Impacting Real Lives
20th March 2020 Dr Solome Okware
2
3
Health Organization of an outbreak
seafood and animal market in Wuhan, China.
government identified the novel corona virus
Health Organization (WHO), declared the current 2019-nCoV
Emergency of International Concern (PHEIC)
4
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
Total countries affected: 176 Total cases: 191,000 Total deaths: 7807
5
respiratory diseases among humans.
not been previously identified in humans.
Middle East Respiratory Syndrome (MERS-CoV), 2012
(zoonotic),once humans are infected, Person-to-person transmission.
6
transmission can occur through droplets or contact.
years(range 15-89 years) (Children 2.4% of all cases)
7
cases
8
WHO
9
Case definitions for surveillance
available and will be revised as new information accumulates. The case definition is used to identify 3 types of cases
10
11
Infection Prevention and Control
Detect: Early detection Prevent: Interrupt transmission Respond: Aggressive supportive care
12
infections in healthcare facilities and the community
13
control
14
severity and presenting symptoms
case definition
entrance of facility
in designated area (source control)
15
16
Category Countries Action Category 1 Italy, San Marino, Iran, South Korea, France, China, Germany, Spain, Belgium, USA, United Kingdom, Netherlands, Sweden, Norway, Austria, Switzerland and Malaysia Postpone travel Self-isolate for 14 days Category 2 Finland, Philippines, Indonesia and Pakistan Observe travellers Category 3 Rest of countries General preventive measures
17
responding
18
19
Cover mouth and nose when coughing and sneezing Maintain social distance (1.5metres) from others
Cover mouth and nose with tissue and dispose of the used tissues in the nearest waste bin
Offer a face mask to patients with suspected 2019-nCoV infection while they are in waiting/public areas or in isolation rooms.
Health workers must put on fit tested N95 masks before entering the patient area or patient care
20
Head cover
Head + hair
Goggle
Eyes Nose + mouth
Gown Face Mask N95 Mask Face shield
Eyes + nose + mouth
Gloves
Hands Nose + mouth
Apron
Body Body
31
transmission
32
symptoms (fever, cough, sneeze)
Remain at home to avoid infecting others.
symptoms such as coughing, sneezing, or running nose
to spit.
33
hygiene and toilet facilities
medication in case of co-morbidity
based hand rub
coughing or sneezing . Through tissue away. Wash hands
handles, bedside tables
36
symptoms) to stay home and seek medical attention
(temp >37.5) in case of an outbreak in Uganda
thumb print machines
37